Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism GLS1 inhibitors(Glutaminase kidney isoform, mitochondrial inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Sitryx Therapeutics Ltd.Startup |
Active Organization Sitryx Therapeutics Ltd.Startup |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Idiopathic Pulmonary Fibrosis | Discovery | GB | Sitryx Therapeutics Ltd.Startup | 31 Mar 2022 |